Related Experiment Videos
Calcium metabolism in essential hypertension: relationship to altered renin system activity
Insights
Hypertension involves calcium metabolism issues. Renin-sodium profiling reveals distinct patient groups with varying calcium levels and responses to treatments like nifedipine and calcium supplements.
Area of Science:
- Nephrology
- Endocrinology
- Cardiovascular Medicine
Background:
- Hypertensive disease is linked to calcium metabolism disturbances, but the precise relationship remains unclear.
- Renin-sodium profiling is a method to categorize hypertensive patients based on metabolic profiles.
Purpose of the Study:
- To investigate the relationship between calcium metabolism abnormalities and renin system activity in essential hypertension.
- To determine if distinct metabolic profiles predict patient response to antihypertensive therapies and dietary interventions.
Main Methods:
- Utilized renin-sodium profiling to categorize essential hypertensive subjects.
- Measured circulating levels of ionized calcium, magnesium, parathyroid hormone, calcitonin, and 1,25-dihydroxyvitamin D (1,25D).
- Assessed blood pressure responses to nifedipine, dietary salt loading, and oral calcium supplementation.
Main Results:
- Identified two distinct hypertensive profiles based on renin activity and calcium metabolism.
- Low-renin subjects with low ionized calcium and high 1,25D showed better responses to nifedipine, salt loading, and calcium supplementation.
- High-renin subjects with high ionized calcium and low 1,25D were less responsive to these interventions.
Conclusions:
- Calcium ionic and hormonal metabolism alterations are linked to renin system activity in hypertension.
- These findings suggest distinct pathophysiological pathways in hypertension based on metabolic profiles.
- Metabolic profiling may guide personalized treatment strategies for hypertensive patients.
Abstract:
Hypertensive disease is associated with various abnormalities of calcium metabolism although how these abnormalities relate to the elevated pressure remains unclear. Based on the use of renin-sodium profiling, we have defined heterogeneous deviations in circulating levels of ionized calcium and magnesium as well as of the calcium-regulating hormones parathyroid hormone, calcitonin, and 1,25-dihydroxyvitamin D (1,25D), which parallel similar deviations in plasma renin activity. Essential hypertensive subjects with a profile of low renin, lower ionized calcium, and elevated 1,25D respond best to the calcium channel blocker nifedipine, demonstrate an enhanced sensitivity to the blood pressure effects of dietary salt loading, and have significantly lower blood pressures in response to oral calcium supplementation. Hypertensive subjects with the opposite metabolic profile--higher renin activity, higher serum ionized calcium, and lower 1,25D levels--are relatively insensitive to the blood pressure effects of either dietary salt loading or nifedipine, and show no significant hypotensive response to calcium supplements. Altogether, these alterations of calcium ionic and hormonal metabolism suggest that the hormonal control of calcium metabolism is linked to renin system activity as well as to the pathophysiology of the hypertensive process.